[Lack of evidence for the inhibition of opioid-related analgesia through peripherally acting μ‑opioid-receptor antagonists].

Michael A. Ueberall, Gerhard H. H. Mueller-Schwefe, Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations. Current Medical Research and Opinion. ,vol. 31, pp. 1413- 1429 ,(2015) , 10.1185/03007995.2015.1047747

William D. Chey, Lynn Webster, Mark Sostek, Jaakko Lappalainen, Peter N. Barker, Jan Tack, Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain The New England Journal of Medicine. ,vol. 370, pp. 2387- 2396 ,(2014) , 10.1056/NEJMOA1310246

L. Webster, W. D. Chey, J. Tack, J. Lappalainen, U. Diva, M. Sostek, Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation Alimentary Pharmacology & Therapeutics. ,vol. 40, pp. 771- 779 ,(2014) , 10.1111/APT.12899

Christina Jagla, Peter Martus, Christoph Stein, Peripheral opioid receptor blockade increases postoperative morphine demands--a randomized, double-blind, placebo-controlled trial. Pain. ,vol. 155, pp. 2056- 2062 ,(2014) , 10.1016/J.PAIN.2014.07.011

Michael Ueberall, Gerhard Mueller-Schwefe, Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids. Journal of Pain Research. ,vol. 8, pp. 459- 475 ,(2015) , 10.2147/JPR.S88076

Michael Ueberall, Alice Eberhardt, Gerhard Mueller-Schwefe, Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice International Journal of General Medicine. ,vol. 9, pp. 39- 51 ,(2016) , 10.2147/IJGM.S94685

Abolfazl Firouzian, Afshin Gholipour Baradari, Abbas Alipour, Amir Emami Zeydi, Alieh Zamani Kiasari, Seyed Abdollah Emadi, Behrooz Kheradmand, Kaveh Hadadi, Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial. Journal of Neurosurgical Anesthesiology. ,vol. 30, pp. 26- 31 ,(2016) , 10.1097/ANA.0000000000000374

Martin Hale, James Wild, Jyotsna Reddy, Tadaaki Yamada, Juan Camilo Arjona Ferreira, Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials. The Lancet Gastroenterology & Hepatology. ,vol. 2, pp. 555- 564 ,(2017) , 10.1016/S2468-1253(17)30105-X

Lynn Webster, Ulysses Diva, Raj Tummala, Mark Sostek, Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation. Pain Practice. ,vol. 18, pp. 505- 514 ,(2018) , 10.1111/PAPR.12640

Nobuyuki Katakami, Toshiyuki Harada, Toru Murata, Katsunori Shinozaki, Masakazu Tsutsumi, Takaaki Yokota, Masatsugu Arai, Yukio Tada, Masaru Narabayashi, Narikazu Boku, Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer Journal of Clinical Oncology. ,vol. 35, pp. 3859- 3866 ,(2017) , 10.1200/JCO.2017.73.0853